2015 Dec 14
Ibrutinib ‘new standard’ for relapsed, refractory mantle cell lymphoma
Peter Martin, comments on phase III trial findings about ibrutinib therapy for relapsed or refractory mantle cell lymphoma. Read more
2015 Dec 14
Lung inflammation contributes to metastasis
Pre-existing inflammation in the lungs may increase the risk that cancers beginning elsewhere will spread to the organ, according to Vivek Mittal, Ph.D., and colleagues. Read more
2015 Dec 14
Amid cancer breakthroughs, hospitals aim for top talent, clinical trials
Dean Laurie Glimcher, M.D., discusses recent big-name cancer recruits at Weill Cornell Medicine. Read more
2015 Dec 11
Surgery in the Aging Patient
Heather Yeo, M.D., MPH, discusses care management for geriatric patients and their caregivers. Read more
2015 Dec 10
Leonard lists his lymphoma highlights
Several trade publications turned to John Leonard, M.D., for his insights into the highlights of the ASH Annual Meeting Read more
2015 Dec 09
How cryotherapy prevents hair loss from chemo
Tessa Cigler, M.D., discusses the use of cool caps during breast cancer treatment. Read more
2015 Dec 02
Modified chemotherapy regimen effective, less toxic for gastric cancers
Manish Shah, M.D., reports on a phase II study about a modified first-line chemo regimen for advanced gastric cancer. Read more
2015 Dec 02
High-End Cancer Treatment for Pets
Kristy Richards, M.D., Ph.D., discusses how cancer research on dogs can benefit humans Read more
2015 Dec 01
Multiple Myeloma: Excitement about monoclonal antibodies
Morton Coleman, M.D., discusses some of the research presented at the recent Lymphoma & Myeloma International Conference. Read more
2015 Dec 01
Taking away the toll
Lisa Roth, M.D., is hoping to change the course of care for children and young adults with Burkitt lymphoma. Read more
2015 Nov 30
Solving the leukemia stem cell conundrum
Monica Guzman, Ph.D., and colleagues are pursuing chemotherapy alternatives for blood cancers like acute myeloid leukemia Read more
2015 Nov 24
Doctors find potential new approach for early detection of myelodysplastic syndromes
Work by Todd Evans, Ph.D., and colleagues has led to a new method to detect earlier stages of myelodysplastic syndromes. Read more
2015 Nov 23
Hematology Drugs in the Pipeline
Several clinicians from Weill Cornell Medicine were called upon to provide insight into promising new hematology drugs. Read more
2015 Nov 20
Prognostic models can have ‘tremendous impact’ on long-term outcomes in CLL
Richard Furman, M.D., offers insights into the development of prognostic models that can identify patients likely to develop resistance to B-cell receptor antagonists. Read more
2015 Nov 20
On the Fast Track
Yariv Houvras, M.D., Ph.D., is using Tri-I TDI funding to pursue new treatment for melanoma. Read more
2015 Nov 18
Melanoma surveillance developments advance goals for improved prognoses
Jonathan Zippin, M.D., Ph.D., is featured in a video discussing advances in melanoma surveillance. Read more
2015 Nov 17
Reflections on the latest treatments for multiple myeloma
Multiple myeloma experts Morton Coleman, M.D., Ruben Niesvizky, M.D, and Tomer Mark, M.D., discuss the latest treatments for the disease. Read more
2015 Nov 17
Companies seek to diagnose cancer from a blood sample
David Lyden, M.D., Ph.D., discusses the benefits and challenges of using exosomes as a diagnostic tool for cancer. Read more
2015 Nov 13
Precision medicine testing options expand with approval of EXaCT-1 test
Whole exome sequencing test developed at Weill Cornell receives state approval for clinical use. Read more
2015 Nov 11
Study of breast cancer metastasis upends conventional wisdom
Discovery by the labs of Ding Cheng Gao and Vivek Mittal may settle a longstanding debate about how cancers spread. Read more
